多灶性小肠类癌的68Ga-DOTATATE PET评估
Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET.
PubMed 文献 · Clin Nucl Med · 2019-01-01
本文报道2例原发性多灶性小肠类癌,采用68Ga-DOTATATE PET/CT评估并与增强CT对照。类癌属神经内分泌肿瘤,表达生长抑素受体2,68Ga-DOTATATE为特异性生长抑素类似物。
要点
- 68Ga-DOTATATE靶向生长抑素受体2,可用于神经内分泌肿瘤显像。
- 本文报道2例原发性多灶性小肠类癌的68Ga-DOTATATE PET/CT表现。
研究设计与样本
- 本文为2例原发性多灶性小肠类癌的病例报告,采用68Ga-DOTATATE PET/CT评估并与增强CT对照。
主要发现
- 2例原发性多灶性小肠类癌经68Ga-DOTATATE PET/CT评估,并附增强CT对照所见。
临床怎么用
- 对怀疑神经内分泌肿瘤(含多灶性小肠类癌)者,可考虑68Ga-DOTATATE PET/CT评估生长抑素受体2表达。
局限性
- 本文仅为2例病例报告,未提供敏感性、特异性等定量诊断效能数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of Ga-DOTATATE PET/CT compared with CT and In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Clark M, Nathan M, Broski SM, et al. Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET. Clin Nucl Med. 2019. PMID: 30762820. doi:10.1097/RLU.0000000000002487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。